Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial
China Medical University Hospital
50 participants
Jun 28, 2023
INTERVENTIONAL
Conditions
Summary
This clinical trial used acupuncture as an adjunctive treatment for glaucoma patients. A randomized, controlled trial involving 50 subjects will be conducted and observed for 12 weeks to evaluate the clinical efficacy of acupuncture. This study aims to provide a reference for future clinical treatment guidelines.
Eligibility
Inclusion Criteria5
- Primary open angle glaucoma diagnosed at least 3 months ago.
- Diagnosed with mild or moderate open angel glaucoma.
- Use 1 or 2 kinds of glaucoma drugs.
- Age ≥ 20 years old.
- Participants sign the informed consent and cooperate with the experimental procedures.
Exclusion Criteria8
- Accept any ophthalmic laser or surgery within one year.
- High myopia.
- Use of any drugs that affect intraocular pressure.
- Visual acuity with correction lower than 0.2.
- Previous or existing uveitis or retinopathy.
- Unable to receive acupuncture treatment continuously or allergic to acupuncture needles.
- Pregnancy or breastfeeding.
- Refusal to sign the informed consent form.
Interventions
The treatment will take place once a week, over six weeks. The needles will placed in the body for 20 minutes. A total of 12 Needles(6 acupoints, bilaterally) will be used in each session.Participants in the treatment group will undergo acupuncture targeting ophthalmology-related acupuncture points, aiming to elicit the 'De Qi' sensation.
A total of 12 Needles(6 acupoints, bilaterally) will be used in each session. Acupuncture points are different from the experimental group.The control group will receive minimum acupuncture stimulation targeting non-ophthalmic acupuncture points without the intention of achieving the 'De Qi' sensation.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05753137